December 18 Nyrada Update  
    Noxopharm Releases Report on Key Progress of Subsidiary Nyrada  
    Noxopharm Subsidiary Nyrada Announces Important Drug Discovery  
    AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough  
    Nyrada- key progress with cholesterol-lowering drug candidate  
    Nyrada, Inc. Newsletter 2. April 2018  
    Nyrada,Inc. Newsletter 1. Jan/Feb 2018  
    Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.  
    Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.  
    US biotech to develop Australian science